Contact

All Stories

  1. Targeting Abnormal PI3K/AKT/mTOR Signaling in Intracerebral Hemorrhage: A Systematic Review on Potential Drug Targets and Influences of Signaling Modulators on Other Neurological Disorders

    Article • Current Reviews in Clinical and Experimental Pharmacology, November 2022, Bentham Science Publishers

    Dr. Sidharth Mehan

  2. Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders

    Article • CNS & Neurological Disorders - Drug Targets, November 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  3. Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders

    Article • Current Molecular Medicine, October 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  4. Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the Brain

    Article • Current Molecular Pharmacology, October 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  5. Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, October 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  6. Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings

    Article • Current Molecular Pharmacology, August 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  7. Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism

    Article • Current Drug Targets, June 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  8. Current Neuropharmacological Interventions in Autism: Potential Drug Targets from Pre-clinical and Clinical Findings

    Article • Current Psychopharmacologye, June 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  9. Neuroprotective Potential of Adenyl Cyclase/cAMP/CREB and Mitochondrial CoQ10 Activator in Amyotrophic Lateral Sclerosis Rats

    Article • Current Bioactive Compounds, June 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  10. Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical Findings

    Article • Current Drug Discovery Technologies, January 2021, Bentham Science Publishers

    Dr. Sidharth Mehan

  11. Sonic Hedgehog Signaling Activation Promotes Cardioprotective Strategies

    Article • Current Signal Transduction Therapy, December 2020, Bentham Science Publishers

    Dr. Sidharth Mehan

  12. Design, synthesis and neuropharmacological evaluation of new 2,4-disubstituted-1,5-benzodiazepines as CNS active agents

    Article • Bioorganic Chemistry, August 2020, Elsevier

    Dr. Sidharth Mehan, Gurpreet Singh

  13. Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats

    Article • IBRO Reports, June 2020, Elsevier

    Dr. Sidharth Mehan

  14. Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats

    Article • Neural Regeneration Research, January 2020, Medknow

    Dr. Sidharth Mehan

  15. Neuroprotective Strategies of Blood-Brain Barrier Penetrant “Forskolin” (AC/cAMP/PKA/CREB Activator) to Ameliorate Mitochondrial Dysfunctioning in Neurotoxic Experimental Model of Autism

    Article • October 2019, IntechOpen

    Dr. Sidharth Mehan

  16. Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings

    Article • CNS & Neurological Disorders - Drug Targets, August 2019, Bentham Science Publishers

    Dr. Sidharth Mehan

  17. Neuroscience Theories, Hypothesis and Approaches to ASD Physiopathology. A Review

    Article • Journal of Neurological Research And Therapy, August 2019, Open Access Pub

    Dr. Sidharth Mehan

  18. Ultraviolet B Phototherapy Intervention in Patients with Multiple Sclerosis: A Prospective, Randomized Pilot Trial

    Article • Journal of Neurological Research And Therapy, August 2019, Open Access Pub

    Dr. Sidharth Mehan

  19. Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings

    Article • Journal of Alzheimer s Disease Reports, July 2019, IOS Press

    Dr. Sidharth Mehan

  20. Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence

    Article • Toxicology Reports, January 2019, Elsevier

    Dr. Sidharth Mehan

  21. Myocardial preconditioning potential of hedgehog activator purmorphamine (smoothened receptor agonist) against ischemia-reperfusion in deoxycortisone acetate salt-induced hypertensive rat hearts

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2019, Medknow

    Dr. Sidharth Mehan

  22. Forskolin, ameliorates mitochondrial dysfunction in Streptozotocin induced diabetic nephropathy in rats

    Article • Asian Journal of Pharmacy and Pharmacology, December 2018, N.S. Memorial Scientific Research and Education Society

    Dr. Sidharth Mehan

  23. Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management

    Article • Neurological Sciences, September 2018, Springer Science + Business Media

    Dr. Sidharth Mehan

  24. Epilepsy: Knowledge and Attitudes of Primary School Teachers in the City of Bouake/Ivory Coast

    Article • Journal of Neurological Research And Therapy, September 2018, Open Access Pub

    Dr. Sidharth Mehan

  25. Short-Term Outcomes of Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson’s Disease - Pilot Study

    Article • Journal of Neurological Research And Therapy, September 2018, Open Access Pub

    Dr. Sidharth Mehan

  26. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction

    Article • Indian Journal of Pharmacology, January 2018, Medknow

    Dr. Sidharth Mehan

  27. Restoration of Mitochondrial Dysfunction in 6-Hydroxydopamine Induced Parkinson’s disease: a Complete Review

    Article • April 2017, Peertechz.com

    Dr. Sidharth Mehan

  28. Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders

    Article • Neural Regeneration Research, January 2017, Medknow

    Dr. Sidharth Mehan

  29. Clinical Therapeutic Strategies to Ameliorate the Mitochondrial ETC Complexes Dysfunctions in Autism: First Time from India

    Article • Virology & Immunology Journal, January 2017, Medwin Publishers

    Dr. Sidharth Mehan

  30. Precautionary Ellagic Acid Treatment Ameliorates Chronically Administered Scopolamine Induced Alzheimer's Type Memory and Cognitive Dysfunctions in Rats

    Article • Pharmacologia, May 2015, Insight Knowledge

    Dr. Sidharth Mehan

  31. Experimental evidence for the potential of lycopene in the management of scopolamine induced amnesia

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Dr. Sidharth Mehan

  32. Renoprotective Effect of Ace Inhibitor-Lisinopril and Heme Oxygenase-1 Inducer-Hemin Combination against Streptozotocin Induced Advanced Diabetic Nephropathy in Rats

    Article • Pharmacologia, February 2014, Insight Knowledge

    Dr. Sidharth Mehan

  33. Spices, Fruits, Nuts and Vitamins: Preventive Interventions for Myocardial Infarction

    Article • Pharmacologia, October 2013, Insight Knowledge

    Dr. Sidharth Mehan

  34. Boswellia serrata-frankincense (A Jesus Gifted Herb); An Updated Pharmacological Profile

    Article • Pharmacologia, June 2013, Insight Knowledge

    Dr. Sidharth Mehan

  35. Cellular Signals like MAPK/NF-kB/m-TOR Mediated Drug Resistance: A Promising Concept in Cancer Research

    Article • Pharmacologia, June 2013, Insight Knowledge

    Dr. Sidharth Mehan

  36. Dementia – A Complete Literature Review on Various Mechanisms Involves in Pathogenesis and an Intracerebroventricular Streptozotocin Induced Alzheimer’s Disease

    Article • February 2012, IntechOpen

    Dr. Sidharth Mehan

  37. JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer’s and Various Neurodegenerative Abnormalities

    Article • Journal of Molecular Neuroscience, September 2010, Springer Science + Business Media

    Dr. Sidharth Mehan

  38. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine — a PDE1 inhibitor

    Article • European Journal of Pharmacology, October 2009, Elsevier

    Dr. Sidharth Mehan